Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 3/20 | 0.52 |
| ▸ | METAP1 | P53582 | 2/20 | 0.52 |
| ▸ | ACP3 | P15309 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5112626 | 0.98 | METAP2 (0.51) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL4826148 | 0.98 | METAP2 (0.51) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL4827716 | 0.98 | METAP2 (0.51) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| SCHEMBL3283005 | 0.82 | ACP3 (0.55) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| SCHEMBL16721027 | 0.79 | METAP2 (0.52) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| SCHEMBL3741224 | 0.79 | METAP2 (0.46) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| SCHEMBL29484443 | 0.79 | ALDH1A1 (0.47) | METAP2METAP1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL4195634 | 0.79 | CYP2C19 (0.47) | METAP2METAP1ACP3ALDH1A1CYP1A2 | |
| SCHEMBL9313554 | 0.79 | ALDH1A1 (0.47) | METAP2METAP1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL7239903 | 0.78 | ACP3 (0.51) | METAP2METAP1ACP3ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6031003-A | TREATING A PATIENT HAVING A DISEASE OR DISORDER TREATABLE BY MODULATING ACTIVITY OF CALCIUM RECEPTORS IN VITRO BY ADMINISTERING A CALCIMIMETIC COMPOUND DETERMINED BY THE CALCILYTIC BOVINE PARATHYROID CELL TEST; OSTEOPOROSIS | NPS PHARMACEUTICALS, INC. (US) | 2000-02-29 | — | — | US | claimed |
| US-6313146-B1 | CAN BE USED FOR THERAPY OF DISEASES OR DISORDERS IN A PATIENT BY MODULATING ONE OR MORE INORGANIC ION RECEPTOR ACTIVITIES | NPS PHARMACEUTICALS, INC. | 2001-11-06 | — | — | US | disclosed |
| US-6031003-A | TREATING A PATIENT HAVING A DISEASE OR DISORDER TREATABLE BY MODULATING ACTIVITY OF CALCIUM RECEPTORS IN VITRO BY ADMINISTERING A CALCIMIMETIC COMPOUND DETERMINED BY THE CALCILYTIC BOVINE PARATHYROID CELL TEST; OSTEOPOROSIS | NPS PHARMACEUTICALS, INC. (US) | 2000-02-29 | — | — | US | disclosed |
| US-5962314-A | CERTAIN CELLS IN THE BODY RESPOND NOT ONLY TO CHEMICAL SIGNALS, BUT ALSO TO IONS SUCH AS EXTRACELLULAR CALCIUM IONS (CA.SUP.2+). THE INVENTION RELATES TO NUCLEIC ACIDS ENCODING SUCH RECEPTORS AND CELLS CONTAINING SUCH NUCLEIC ACIDS. | NPS PHARMACEUTICALS, INC. (US) | 1999-10-05 | — | — | US | disclosed |